These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 39217916
1. The role of M1 (CD11c) and M2 (CD163) interplay in the pathogenesis of oral submucous fibrosis and its malignant transformation: An immunohistochemical analysis. Parekh NM, Desai RS, Bansal SP, Shirsat PM, Prasad PS. Cytokine; 2024 Nov; 183():156742. PubMed ID: 39217916 [Abstract] [Full Text] [Related]
2. The Role of Increased Connective Tissue Growth Factor in the Pathogenesis of Oral Submucous Fibrosis and its Malignant Transformation-An Immunohistochemical Study. Shah AM, Jain K, Desai RS, Bansal S, Shirsat P, Prasad P, Bodhankar K. Head Neck Pathol; 2021 Sep; 15(3):817-830. PubMed ID: 33544386 [Abstract] [Full Text] [Related]
12. Ki67, CD105, and α-SMA expression supports the transformation relevant dysplastic features in the atrophic epithelium of oral submucous fibrosis. Gadbail AR, Chaudhary M, Sarode SC, Gondivkar S, Tekade SA, Zade P, Hande A, Sarode GS, Patil S. PLoS One; 2018 Jul; 13(7):e0200171. PubMed ID: 30001387 [Abstract] [Full Text] [Related]
13. Malignant transformation of oral submucous fibrosis: overview of histopathological aspects. Ray JG, Ranganathan K, Chattopadhyay A. Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):200-9. PubMed ID: 27422418 [Abstract] [Full Text] [Related]
14. Survivin as a potential early marker in the carcinogenesis of oral submucous fibrosis. Zhou S, Qu X, Yu Z, Zhong L, Ruan M, Ma C, Wang M, Zhang C, Jian X. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Apr; 109(4):575-81. PubMed ID: 20303055 [Abstract] [Full Text] [Related]